XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsexelixis-reports-updated-phase-ib-data-cobimetinib-in-combination-vemurafenib/20%Daily2013-09-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdiamedica-reports-promising-results-from-phase-iii-study-of-diabetes-drug/20%Daily2013-09-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdurata-files-nda-of-dalbavancin-fda-treatment-skin-infections/20%Daily2013-09-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newszalicus-gets-fda-orphan-drug-status-for-pain-drug/20%Daily2013-09-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgilead-sciences-gets-eu-approval-for-new-boosting-agent-for-hiv-therapy/20%Daily2013-09-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslumena-starts-lum001-clinical-programme-in-children-with-algs/20%Daily2022-03-07 09:09
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-gets-european-approval-three-new-type-2-diabetes-therapies/20%Daily2013-09-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssunesis-completes-enrolment-in-phase-iii-study-of-leukemia-drug/20%Daily2013-09-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiomarin-initiates-dosing-phase-iii-neurodegenerative-disorder-study/20%Daily2013-09-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-accepts-neurovances-ind-application-for-adhd-drug/20%Daily2013-09-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseleven-biotherapeutics-presents-promising-clinical-data-on-eye-drug/20%Daily2013-09-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsablynx-signs-840m-drug-licensing-deal-with-abbvie/20%Daily2013-09-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsomeros-begins-enrolment-in-phase-ii-clinical-study-of-schizophrenia-drug/20%Daily2013-09-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-and-prosensas-muscular-dystrophy-drug-fails-primary-endpoint-phase-iii-study/20%Daily2013-09-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscreabilis-initiates-treatment-phase-iib-study-dermatitis-drug/20%Daily2013-09-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncomed-starts-phase-ibii-study-of-anti-cancer-stem-cell-drug/20%Daily2013-09-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsregado-initiates-enrolment-in-phase-iii-study-of-antithrombotic-drug-system-reg1/20%Daily2013-09-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsviralytics-phase-ii-clinical-trial-of-melanoma-drug-meets-primary-endpoint/20%Daily2013-09-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsus-fda-approves-generic-version-roches-cancer-drug-xeloda/20%Daily2013-09-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdendreon-gets-eu-marketing-authorisation-for-prostate-cancer-vaccine/20%Daily2013-09-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscancer-research-technology-teva-partner-develop-new-cancer-drugs/20%Daily2013-09-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsceltaxsys-completes-phase-i-study-of-ctx-4430-in-cystic-fibrosis-patients/20%Daily2013-09-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-arbor-sign-licensing-agreement-for-blood-pressure-drugs-us/20%Daily2013-09-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalexion-pharmas-soliris-drug-obtains-japanese-approval-treatment-ahus/20%Daily2013-09-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newskiadis-pharma-completes-follow-up-phase-iii-study-atir/20%Daily2013-09-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscivitas-therapeutics-receives-38m-financing-for-development-inhaled-parkinsons-drug/20%Daily2013-09-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsironwood-and-astrazeneca-start-phase-iii-study-of-linaclotide-in-china/20%Daily2013-09-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgilead-files-nda-of-idelalisib-with-fda-for-treatment-of-indolent-non-hodgkins-lymphoma/20%Daily2013-09-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newszalicus-starts-phase-ib-clinical-trial-of-neuropathic-pain-drug/20%Daily2013-09-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsconatus-begins-dosing-phase-ii-trial-emricasan-alcoholic-hepatitis-patients/20%Daily2013-09-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspaxvax-starts-phase-iii-clinical-trial-for-single-dose-oral-cholera-vaccine/20%Daily2013-09-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsactivaero-chiesi-develop-new-treatment-solution-cystic-fibrosis-patients/20%Daily2013-09-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsks-phase-iii-study-in-melanoma-fails-co-primary-endpoint/20%Daily2013-09-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscelgenes-abraxane-gets-fda-approval-for-late-stage-pancreatic-cancer/20%Daily2013-09-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstakedas-ulcerative-colitis-treatment-gets-us-fda-priority-review-status/20%Daily2013-09-05 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscivitas-therapeutics-starts-phase-iib-clinical-trial-treatment-parkinsons-disease/20%Daily2013-09-05 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbristol-myers-squibb-pfizer-announce-results-subanalysis-phase-iii-aristotle-trial-eliquis/20%Daily2013-09-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastrazeneca-launches-phase-iii-clinical-trial-of-olaparib-cancer-drug/20%Daily2013-09-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdebiopharm-starts-phase-i-study-of-cancer-drug/20%Daily2013-09-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsapitope-completes-phase-i-clinical-study-of-multiple-sclerosis-drug/20%Daily2013-09-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsabbvie-commences-second-phase-iii-study-elagolix-endometriosis/20%Daily2013-09-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsks-melanoma-drug-receives-european-approval/20%Daily2013-09-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsicr-researchers-identify-new-drug-target-for-squamous-cell-lung-cancer/20%Daily2013-09-01 17:30
https://www.clinicaltrialsarena.com/marketdata/feature-august-stories-bayer-compugen-partner-cancer-immunotherapy/20%Daily2013-09-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsdaiichi-sankyos-phase-iii-hokusai-vte-study-meets-primary-efficacy-endpoint/20%Daily2013-09-01 17:30